Download A4Medicine Mobile App
Empower Your RCGP AKT Journey: Master the MCQs with Us!
The tables below serve as a quick reference guide for clinicians, particularly in primary care settings, on the multifaceted aspects of Skin Prick Testing (SPT). It delineates the methodological and clinical utility and extends to the interpretation of results, contraindications, and the impact of medications on test outcomes. By integrating historical background, mechanisms of action, and relative contraindications, this table aims to equip healthcare professionals with the requisite knowledge to diagnose and manage IgE-mediated allergic conditions using SPT accurately.
| Attribute | Description and Elaboration |
|---|---|
| Methodology | Epicutaneous introduction of allergen extracts with a lancet, typically to the volar aspect of the forearm. This method is minimally invasive and inexpensive. |
| Historical Background | First introduced by Helmtraud Ebruster in 1959, SPT has since undergone various modifications and interpretations, making comparability challenging. Different allergen extracts used globally also impact data comparability. |
| Clinical Utility | Reliable for diagnosing IgE-mediated allergies including rhinoconjunctivitis, asthma, urticaria, anaphylaxis, atopic eczema, and suspected food and drug allergies. Helps confirm type I hypersensitivity reactions and provides immediate results. |
| Mechanism of Action | The introduction of allergens into the skin leads to cross-linking of specific IgE on mast cells, triggering their degranulation and the release of histamine and other mediators. This results in a... |
Try our Free Plan to get the full article.
